Literature DB >> 23116010

Multivalent ligand: design principle for targeted therapeutic delivery approach.

Chuda Chittasupho1.   

Abstract

Multivalent interactions of biological molecules play an important role in many biochemical events. A multivalent ligand comprises of multiple copies of ligands conjugated to scaffolds, allowing the simultaneous binding of multivalent ligands to multiple binding sites or receptors. Many research groups have successfully designed and synthesized multivalent ligands to increase the binding affinity, avidity and specificity of the ligand to the receptor. A multimeric ligand is a promising option for the specific treatment of diseases. In this review, the factors affecting multivalent interactions, including the size and shape of the ligand, geometry and an arrangement of ligands on the scaffold, linker length, thermodynamic, and kinetics of the interactions are discussed. Examples of the multivalent ligand applications for therapeutic delivery are also summarized.

Mesh:

Substances:

Year:  2012        PMID: 23116010     DOI: 10.4155/tde.12.99

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  14 in total

1.  Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer Nanoparticles.

Authors:  Marian A Ackun-Farmmer; Kharimat L Alatise; Griffin Cross; Danielle S W Benoit
Journal:  Adv Biosyst       Date:  2020-10-19

2.  Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.

Authors:  Nino Kvirkvelia; Malgorzata McMenamin; Vanessa Iris Gutierrez; Besarion Lasareishvili; Michael P Madaio
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

3.  Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.

Authors:  Baksun Kim; Jaeho Shin; Junmin Wu; David T Omstead; Tanyel Kiziltepe; Laurie E Littlepage; Basar Bilgicer
Journal:  J Control Release       Date:  2020-04-08       Impact factor: 9.776

Review 4.  Principles in the design of ligand-targeted cancer therapeutics and imaging agents.

Authors:  Madduri Srinivasarao; Chris V Galliford; Philip S Low
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

5.  Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines.

Authors:  Te-Wei Chu; Jindřich Kopeček
Journal:  Biomater Sci       Date:  2015-07       Impact factor: 6.843

Review 6.  Multivalent polymers for drug delivery and imaging: the challenges of conjugation.

Authors:  Mallory A van Dongen; Casey A Dougherty; Mark M Banaszak Holl
Journal:  Biomacromolecules       Date:  2014-08-22       Impact factor: 6.988

Review 7.  Critical parameters for design and development of multivalent nanoconstructs: recent trends.

Authors:  Avijit Kumar Bakshi; Tanweer Haider; Rahul Tiwari; Vandana Soni
Journal:  Drug Deliv Transl Res       Date:  2022-01-11       Impact factor: 5.671

8.  Avidity observed between a bivalent inhibitor and an enzyme monomer with a single active site.

Authors:  Shiran Lacham-Hartman; Yulia Shmidov; Evette S Radisky; Ronit Bitton; David B Lukatsky; Niv Papo
Journal:  PLoS One       Date:  2021-11-30       Impact factor: 3.752

9.  Discovery of unusual dimeric piperazyl cyclopeptides encoded by a Lentzea flaviverrucosa DSM 44664 biosynthetic supercluster.

Authors:  Chunshun Li; Yifei Hu; Xiaohua Wu; Spencer D Stumpf; Yunci Qi; John M D'Alessandro; Keshav K Nepal; Ariel M Sarotti; Shugeng Cao; Joshua A V Blodgett
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-19       Impact factor: 12.779

10.  Avidity mechanism of dendrimer-folic acid conjugates.

Authors:  Mallory A van Dongen; Justin E Silpe; Casey A Dougherty; Ananda Kumar Kanduluru; Seok Ki Choi; Bradford G Orr; Philip S Low; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2014-04-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.